| Catalog No. | HY258026 |
|---|
| Species reactivity | Human |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Isotype | Recombinant human granulocyte colony-stimulating factor (G-CSF) analogue |
|---|
| Expression system | Mammalian Cells |
|---|
| Target | C17orf33, Lenograstim, CSF3, Pluripoietin, Filgrastim, Granulocyte colony-stimulating factor, GCSF, G-CSF |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Purified by nickel column chromatography. |
|---|
| Accession | P09919 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Alternate Names | CAS:208265-92-3 |
|---|
| Background | Pegfilgrastim, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).Pegfilgrastim was developed by Amgen. |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
